SMPD2 and prostate carcinoma: In colon and prostate cancer, the inhibition of EV PD-L1 from the tumor cells with a Rab27a or genetic deletion (knockdown, K/D) of neutral sphingomyelinase gene (nSMase) suppressed tumor growth in an immune-dependent manner 16.